| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President, Global A &M A | EVP, Global A &M Adherence +2 more
1 company
Seim Robin Gene is a Director at OMCL. Recent filings cover 0 purchases and 20 sales. Those positions are worth an estimated $1.7M at current prices.
Seim Robin Gene's largest disclosed position is in OMCL as Director, worth about $1.7M. The recent filings there lean toward selling, a net 152,235 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 26, 2016 | OMCL Omnicell, Inc. | EVP, Global A &M Adherence | Sell | 767 | $30.00 | $23,010.00 | -1.3% | |
| Aug 13, 2015 | OMCL Omnicell, Inc. | Executive VP And CFO | Sale+OE | 23,946 | $35.63 | $853,212.45 | -17.6% | |
| Jul 1, 2015 | OMCL Omnicell, Inc. | Executive VP And CFO | Sale+OE | 19,582 | $37.84 | $741,061.21 | -23.6% | |
| Jan 2, 2015 | OMCL Omnicell, Inc. | Executive VP And CFO | Sell | 1,948 | $32.36 | $63,037.28 | -3.2% |